QA108 Phase II Study in Subjects With Intermediate Age-Related Macular Degeneration
Clinical trial NCT05562219 · COMPLETED
Trial details
- NCT number
- NCT05562219
- Sponsor
- Smilebiotek Zhuhai Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-29
- Primary completion
- 2024-06-24
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.